Laboratory of Synaptogenesis, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wrocław, Poland.
Sci Rep. 2020 Mar 11;10(1):4524. doi: 10.1038/s41598-020-61347-x.
Motor neurons form specialized synapses with skeletal muscle fibers, called neuromuscular junctions (NMJs). Cultured myotubes are used as a simplified in vitro system to study the postsynaptic specialization of muscles. The stimulation of myotubes with the glycoprotein agrin or laminin-111 induces the clustering of postsynaptic machinery that contains acetylcholine receptors (AChRs). When myotubes are grown on laminin-coated surfaces, AChR clusters undergo developmental remodeling to form topologically complex structures that resemble mature NMJs. Needing further exploration are the molecular processes that govern AChR cluster assembly and its developmental maturation. Here, we describe an improved protocol for culturing muscle cells to promote the formation of complex AChR clusters. We screened various laminin isoforms and showed that laminin-221 was the most potent for inducing AChR clusters, whereas laminin-121, laminin-211, and laminin-221 afforded the highest percentages of topologically complex assemblies. Human primary myotubes that were formed by myoblasts obtained from patient biopsies also assembled AChR clusters that underwent remodeling in vitro. Collectively, these results demonstrate an advancement of culturing myotubes that can facilitate high-throughput screening for potential therapeutic targets for neuromuscular disorders.
运动神经元与骨骼肌纤维形成特殊的突触,称为神经肌肉接头(NMJ)。培养的肌管被用作研究肌肉突触后特化的简化体外系统。用糖蛋白层粘连蛋白或层粘连蛋白-111 刺激肌管会诱导包含乙酰胆碱受体(AChR)的突触后机制的聚集。当肌管在涂有层粘连蛋白的表面上生长时,AChR 簇经历发育重塑,形成拓扑复杂的结构,类似于成熟的 NMJ。需要进一步探索的是控制 AChR 簇组装及其发育成熟的分子过程。在这里,我们描述了一种改良的肌肉细胞培养方案,以促进复杂 AChR 簇的形成。我们筛选了各种层粘连蛋白同工型,并表明层粘连蛋白-221 最能诱导 AChR 簇,而层粘连蛋白-121、层粘连蛋白-211 和层粘连蛋白-221 则提供了最高百分比的拓扑复杂组装体。由患者活检获得的成肌细胞形成的人原代肌管也组装了 AChR 簇,这些 AChR 簇在体外经历了重塑。总的来说,这些结果表明肌管培养的进展可以促进针对神经肌肉疾病的潜在治疗靶点的高通量筛选。